CN104352995A - 一种治疗胆结石的药物及其制备方法 - Google Patents
一种治疗胆结石的药物及其制备方法 Download PDFInfo
- Publication number
- CN104352995A CN104352995A CN201410703685.6A CN201410703685A CN104352995A CN 104352995 A CN104352995 A CN 104352995A CN 201410703685 A CN201410703685 A CN 201410703685A CN 104352995 A CN104352995 A CN 104352995A
- Authority
- CN
- China
- Prior art keywords
- radix
- grams
- gram
- fructus
- pick
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 229940079593 drug Drugs 0.000 title claims description 13
- 208000001130 gallstones Diseases 0.000 title abstract 3
- 210000003038 endothelium Anatomy 0.000 claims abstract description 11
- 238000005202 decontamination Methods 0.000 claims description 18
- 230000003588 decontaminative effect Effects 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 201000001883 cholelithiasis Diseases 0.000 claims description 16
- 239000012535 impurity Substances 0.000 claims description 12
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 8
- 210000002216 heart Anatomy 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 4
- 238000009738 saturating Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 claims description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 2
- 235000014375 Curcuma Nutrition 0.000 claims description 2
- 244000164439 Curcuma angustifolia Species 0.000 claims description 2
- 241000202807 Glycyrrhiza Species 0.000 claims description 2
- 241000612166 Lysimachia Species 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 241000238370 Sepia Species 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 230000007159 enucleation Effects 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 208000004880 Polyuria Diseases 0.000 abstract description 7
- 230000035619 diuresis Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 3
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 1
- 241000092668 Artemisia capillaris Species 0.000 abstract 1
- 241001571764 Lysimachia christinae Species 0.000 abstract 1
- 241000245665 Taraxacum Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 244000290970 Tetrapanax papyrifer Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000006870 function Effects 0.000 description 21
- 239000008280 blood Substances 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 20
- 239000000796 flavoring agent Substances 0.000 description 19
- 235000019634 flavors Nutrition 0.000 description 19
- 208000002193 Pain Diseases 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 15
- 230000036407 pain Effects 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 9
- 210000001015 abdomen Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 208000001848 dysentery Diseases 0.000 description 7
- 208000004998 Abdominal Pain Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 208000002881 Colic Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010046814 Uterine prolapse Diseases 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 210000004914 menses Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000001314 paroxysmal effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000820 toxicity test Toxicity 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 201000002045 Ancylostomiasis Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000033211 Ankylostomiasis Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010004663 Biliary colic Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020376 Hookworm infection Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033664 Panic attack Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 239000003809 bile pigment Substances 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 231100000359 cholestasis Toxicity 0.000 description 1
- 230000007870 cholestasis Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000001515 vagal effect Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗胆结石的药物及其制备方法,其主要是由茵陈蒿、金钱草、蒲公英、通草、郁金、鸡内金、山楂、水牛角、柴胡、香附、丹参、枳壳、川楝子按一定重量配比制备而成,本发明药物具有清热解毒,利尿散结的功效,用于治疗胆结石疗程短,见效快,无毒副作用。
Description
技术领域
本发明涉及一种治疗胆结石的药物及其制备方法,属中药领域。
背景技术
胆结石主要见于成人,女性多于男性,40岁后发病率随年龄增长而增高。结石为胆固醇结石或以胆固醇为主的混合性结石和黑色胆色素结石。胆结石与多种因素有关。任何影响胆固醇与胆汁酸浓度比例改变和造成胆汁淤滞的因素都能导致结石形成。目前,西药治疗胆结石效果不佳,而长期服用西药有较多副作用,因此,人们对快速有效治疗胆结石的中药存在很大的需求。
发明内容
本发明人经过反复的研究及临床的试验和验证,终于找到了有效治疗胆结石的药物,从而完成了本发明。
本发明的目的就是提供一种能够有效治疗胆结石的组合药物。
本发明的另一个目的就是提供了该组合药物的制备方法。
本发明药物是选用茵陈蒿、金钱草、蒲公英、通草、郁金、鸡内金、山楂、水牛角、柴胡、香附、丹参、枳壳、川楝子、黄芪、海螵蛸、白芍、乌梅、大黄、麦门冬、甘草药物进行组合的,将这些药物组合使得各药物功效产生协同作用,从而能够有效治疗胆结石的复发。其中选用茵陈蒿是因为其性味苦辛,凉,入肝、脾、膀胱经,有清热利湿的功能,治湿热黄疸,小便不利,风痒疮疥。选用金钱草是因为其性味苦辛,凉,有清热,利尿,镇咳,消肿,解毒的功能,治黄疸,水肿,膀胱结石,疟疾,肺痈,咳嗽,吐血,淋浊,带下,风湿痹痛,小儿疳积,惊癎,痈肿,疮癣,湿疹。选用蒲公英是因为其性味苦甘,寒,入肝、胃经,有清热解毒,利尿散结的功能,治急性乳腺炎,淋巴腺炎,瘰疬,疔毒疮肿,急性结膜炎,感冒发热,急性扁桃体炎,急性支气管炎,胃炎,肝炎,胆囊炎,尿路感染。选用通草是因为其性味甘淡,凉,入肺、胃经,有泻肺,利小便,下乳汁的功能,治小便不利,淋病,水肿,产妇乳汁不通,目昏,鼻塞。选用郁金是因为其性味辛苦,凉,入心、肺、肝经,有行气解随,凉血破瘀的功能,治胸腹胁肋诸痛,失心癫狂,热病神昏,吐血,衄血,尿血,血淋,妇女倒经,黄疸。选用鸡内金是因为其性味甘,平,入脾、胃经,有治积滞,健脾胃的功能,治食积胀满,呕吐反胃,泻痢,疳积,消渴,遗溺,喉痹乳蛾,牙疳口疮。选用山楂是因为其性味酸甘,微温,入脾、胃、肝经,有消食积,散瘀血,驱绦虫的功能,治肉积,癥瘕,痰饮,痞满,吞酸,泻痢,肠风,腰痛,疝气,产后儿枕痛,恶露不尽,小儿乳食停滞。选用水牛角是因为其性味苦咸,寒,有清热、凉血、解毒的功能,治热病头痛,壮热神昏,斑疹,吐衄,小儿惊风,喉痹咽肿。选用柴胡是因为其性味苦,凉,入肝、胆经,有和解表里,疏肝,升阳的功能,治寒热往来,胸满胁痛,口苦耳聋,头痛目眩,疟疾,下利脱肛,月经不调,子宫下垂。选用香附是因为其性味辛微苦干,平,入肝、三焦经,有理气解郁,止痛调经的功能,治肝胃不和,气郁不舒,胸腹胁肋胀痛,痰饮痞满,月经不调,崩漏带下。选用丹参是因为其性味苦,微温,入心、肝经,有活血去瘀,安神宁心,排脓,止痛的功能,治心绞痛,月经不调,痛经,以闭,血崩带下,癥瘕,积聚,瘀血腹痛,骨节疼痛,惊悸不眠,恶疮肿毒。选用枳壳是因为其性味苦辛,凉,入肺、脾、大肠经,有破气,行痰,消积的功能,治胸膈痰滞,胸痞,胁胀,食积,噫气,呕逆,下痢后重,脱肛,子宫脱垂。选用川楝子是因为其性味苦,寒,有毒,入肝、胃、小肠经,有降湿热,清肝火,止痛,杀虫的功能,治热厥心痛,胁痛,疝痛,虫积腹痛。选用黄芪是因为其性味甘,微温,入肺、脾经,生用有益卫固表,利水消肿,托毒,生肌的功能,治自汗,盗汗,血痹,浮肿,痈疽不溃或溃久敛;炙用有补中益的功能,治内伤劳倦,脾虚泄泻,脱肛,气虚血脱,崩带及一切气衰血虚之症。选用海螵蛸是因为其性味咸,微温,入肝、肾经,有除湿,制酸,止血,敛疮的功能,治胃痛吞酸,吐、衄、呕血,便血,崩漏带下,血枯经闭,腹痛癥瘕,虚疟泻痢,阴蚀烂疮。选用白芍是因为其性味苦酸,凉,入肝、脾经,有养血柔肝,缓中止痛,敛阴收汗的功能,治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热,月经不调,崩漏,带下。选用乌梅是因为其性味酸,温,入肝,脾,肺,大肠经,有收敛生津,安蛔驱虫的功能,治久咳,虚热烦渴,久疟,痢疾,便血,尿血,血崩,蛔厥腹痛,呕吐,钩虫病,牛皮癣,胬肉。选用大黄是因为其性味苦、寒,入胃、大肠、肝径,有泻热毒,破积滞,行瘀血的功能,治实热便秘,谵语发狂,食积痞满,痢疾初起,里急后重,瘀停经闭,癥瘕积聚,时行热疫,暴眼赤痛,吐血,衄血,阳黄,水肿,淋浊,溲赤,痈疡肿毒,疔疮,汤火伤。选用麦门冬是因为其性味甘微苦,寒,入肺、胃、心经,有养阴润肺,清心除烦,益胃生津的功能,治肺燥干咳,吐血,咯血,肺痿,肺痈,虚劳烦热,清渴,热病津伤,咽干口燥,便秘。选用甘草是因为其性味甘平,入脾、胃、肺经,有和中缓急,润肺,解毒,调和诸药的功能,炙用治脾胃虚弱,食少,腹痛便溏,劳倦发热,肺痿咳嗽,心悸,惊痈,生用治咽喉肿痛,消化性溃疡,痈疽疮疡,解药毒及食物中毒。
本发明组合的药物用量也是发明人经过大量摸索总结得出的,各组分的用量在下述重量范围内都具有较好疗效:
茵陈蒿 25-30克 金钱草 25-30克 蒲公英 25-30克
通 草 15-20克 郁 金 15-20克 鸡内金 15-20克
山 楂 15-20克 水牛角 15-20克 柴 胡 10-15克
香 附 10-15克 丹 参 10-15克 枳 壳 10-15克
川楝子 10-15克 黄 芪 10-15克 海螵蛸 10-15克
白 芍 10-15克 乌 梅 3-5克 大 黄 3-5克
麦门冬 3-5克 甘 草 3-5克
优选用量为:
茵陈蒿 27克 金钱草 27克 蒲公英 27克
通 草 17克 郁 金 17克 鸡内金 17克
山 楂 17克 水牛角 17克 柴 胡 13克
香 附 13克 丹 参 13克 枳 壳 13克
川楝子 13克 黄 芪 13克 海螵蛸 13克
白 芍 13克 乌 梅 4克 大 黄 4克
麦门冬 4克 甘 草 4克
本发明药物的制备方法如下:
一、备料
1、茵陈蒿:过筛,拣去杂质,除去残根,碾碎,再过筛去净泥屑;
2、金钱草:拣净杂质,筛去灰屑,晒干;
3、蒲公英:拣去杂质,洗净泥土,切段,晒干;
4、通草:拣去杂质,切片;
5、郁金:用水浸泡,洗净,捞出晒晾,润透,切片,晒干;
6、鸡内金:拣去杂质,漂净晒干;
7、山楂:拣净杂质,筛去核;
8、水牛角:劈开,用热水浸泡,捞出,镑片,晒干;
9、柴胡:拣去杂质,除去残茎,洗净泥沙,捞出,润透后及时切片,随即晒干;
10、香附:拣去杂质,碾成碎粒,簸去细毛及细末;
11、丹参:拣净杂质,除去根茎,洗净,捞出,润透后切片,晾干;
12、枳壳:除去瓤、核,冼净,稍浸,捞出,润软,以手能捏对折为止,切片,晾干;
13、川楝子:拣去杂质,洗净,烘干,轧碎或劈成两半;
14、黄芪:拣净杂质,除去残留的根头和空心较大的根,用水浸泡,捞出,润透后及时切片,晒干;
15、海螵蛸:刷洗干净,晒干,砸成小块;
16、白芍:拣去杂质,分开大小个,用水浸泡至八成透,捞出,晒晾,切片,干燥;
17、乌梅:拣净杂质,筛去灰屑,洗净,晒干;
18、大黄:取切成小块的生大黄,用黄酒拌匀,放蒸笼内蒸制,或置罐内密封,坐水锅中,隔水蒸透,取出晒干,大黄块100斤,用黄酒40斤;
19、麦门冬:拣净杂质,用水浸泡,捞出,润透后抽去心,再洗净晒干;
20、甘草:拣去杂质,洗净,用水浸泡至八成透时,捞出,润透,切片,晾干。
二、制备
1、将所述重量的茵陈蒿、金钱草、蒲公英、通草、郁金、鸡内金、山楂、水牛角、柴胡、香附、丹参、枳壳、川楝子、黄芪、海螵蛸、白芍、乌梅、大黄、麦门冬、甘草药物加8倍量水进行浸泡,浸泡60分钟后,武火煎煮沸腾10分钟,再用文火煎煮30分钟过滤得第一次煎煮液倒入容器内。
2、将过滤的药渣加水6倍量,武火煎煮沸腾,再用文火煎煮30分钟,过滤得第二次煎煮液。
3、将两次煎煮液混合,即得药液,将药液分为4剂服用。
本发明选用蒲公英为君药,柴胡、通草为臣药,丹参为佐,甘草为使,将上述药物与诸药组合制成治疗胆结石的药物。
本发明药物具有清热解毒,泄瘀清火,利尿散结的功效,用于治疗胆结石,疗程短、见效快、治愈后不复发、无毒副作用。
具体实施方式:
以下通过试验例来进一步阐述本发明所述药物的有益效果,这些试验例包括了本发明药物的动物毒性试验报告和临床观察资料。
[试验例1]本发明药物的动物毒性试验报告:
取家兔30只,雌雄兼用,体重2.0—2.5kg,分两组,每组15只,其中一组为超剂量试验组,另一组为正常量试验组。超常量组为20ml/kg,正常量为10ml/kg,给药方式为灌胃法给药,每天两次,连服7天,每天观察给药反应,结果表明二组家兔活动、饮食正常,药物无不良毒副作用。
[试验例2]本发明药物治疗胆结石的临床观察资料:
1、一般资料
收治门诊患者共36例。
2、诊断标准
疾病症状:
病人常在饱餐、进食油腻食物后或睡眠中体位改变时,由于胆囊收缩或结石移位加上迷走神经兴奋,结石嵌顿在胆囊壶腹部或颈部,胆囊排空受阻,胆囊内压力升高,胆囊强力收缩而引起绞痛。疼痛位于右上腹或上腹部,呈阵发性,或者持续疼痛阵发性加剧,可向右肩胛部和背部放射,可伴恶心、呕吐。部分病人因痛剧而不能准确说出疼痛部位。首次胆绞痛出现后,约70%的病人一年内会复发。
3、治疗方法
选用上述药剂,给患者服用,每次服用1剂,每天早、晚各服1次,15天为一个疗程,连续服用3个疗程。
4、疗效评定标准
显效:胆结石症状消失,体质恢复正常,观察半年无复发者;
好转:胆结石症状明显好转,疼痛发作期延长,发作时疼痛症状减轻;
无效:达不到好转标准者。
5、治疗结果(见下表)
在上述的治疗中,用本发明药物治疗胆结石患者36例,结果显效28例,显效率为77.78%,好转6例,好转率为16.67%,无效2例,总有效率为94.45%。
Claims (3)
1.一种治疗胆结石的药物,其特征求在于:它是由下列重量范围内的原料药制成:
茵陈蒿 25-30克 金钱草 25-30克 蒲公英 25-30克
通 草 15-20克 郁 金 15-20克 鸡内金 15-20克
山 楂 15-20克 水牛角 15-20克 柴 胡 10-15克
香 附 10-15克 丹 参 10-15克 枳 壳 10-15克
川楝子 10-15克 黄 芪 10-15克 海螵蛸 10-15克
白 芍 10-15克 乌 梅 3-5克 大 黄 3-5克
麦门冬 3-5克 甘 草 3-5克 。
2.根据权利要求1所述的药物,其中各原料药的用量为:
茵陈蒿 27克 金钱草 27克 蒲公英 27克
通 草 17克 郁 金 17克 鸡内金 17克
山 楂 17克 水牛角 17克 柴 胡 13克
香 附 13克 丹 参 13克 枳 壳 13克
川楝子 13克 黄 芪 13克 海螵蛸 13克
白 芍 13克 乌 梅 4克 大 黄 4克
麦门冬 4克 甘 草 4克。
3.根据权利要求1或2所述药物的制备方法,其特征在于:它包括下列步骤:
一、备料
1、茵陈蒿:过筛,拣去杂质,除去残根,碾碎,再过筛去净泥屑;
2、金钱草:拣净杂质,筛去灰屑,晒干;
3、蒲公英:拣去杂质,洗净泥土,切段,晒干;
4、通草:拣去杂质,切片;
5、郁金:用水浸泡,洗净,捞出晒晾,润透,切片,晒干;
6、鸡内金:拣去杂质,漂净晒干;
7、山楂:拣净杂质,筛去核;
8、水牛角:劈开,用热水浸泡,捞出,镑片,晒干;
9、柴胡:拣去杂质,除去残茎,洗净泥沙,捞出,润透后及时切片,随即晒干;
10、香附:拣去杂质,碾成碎粒,簸去细毛及细末;
11、丹参:拣净杂质,除去根茎,洗净,捞出,润透后切片,晾干;
12、枳壳:除去瓤、核,冼净,稍浸,捞出,润软,以手能捏对折为止,切片,晾干;
13、川楝子:拣去杂质,洗净,烘干,轧碎或劈成两半;
14、黄芪:拣净杂质,除去残留的根头和空心较大的根,用水浸泡,捞出,润透后及时切片,晒干;
15、海螵蛸:刷洗干净,晒干,砸成小块;
16、白芍:拣去杂质,分开大小个,用水浸泡至八成透,捞出,晒晾,切片,干燥;
17、乌梅:拣净杂质,筛去灰屑,洗净,晒干;
18、大黄:取切成小块的生大黄,用黄酒拌匀,放蒸笼内蒸制,或置罐内密封,坐水锅中,隔水蒸透,取出晒干,大黄块100斤,用黄酒40斤;
19、麦门冬:拣净杂质,用水浸泡,捞出,润透后抽去心,再洗净晒干;
20、甘草:拣去杂质,洗净,用水浸泡至八成透时,捞出,润透,切片,晾干;
二、制备
1、将所述重量的茵陈蒿、金钱草、蒲公英、通草、郁金、鸡内金、山楂、水牛角、柴胡、香附、丹参、枳壳、川楝子、黄芪、海螵蛸、白芍、乌梅、大黄、麦门冬、甘草药物加8倍量水进行浸泡,浸泡60分钟后,武火煎煮沸腾10分钟,再用文火煎煮30分钟过滤得第一次煎煮液倒入容器内,
2、将过滤的药渣加水6倍量,武火煎煮沸腾,再用文火煎煮30分钟,过滤得第二次煎煮液,
3、将两次煎煮液混合,即得药液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410703685.6A CN104352995A (zh) | 2014-11-30 | 2014-11-30 | 一种治疗胆结石的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410703685.6A CN104352995A (zh) | 2014-11-30 | 2014-11-30 | 一种治疗胆结石的药物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104352995A true CN104352995A (zh) | 2015-02-18 |
Family
ID=52520368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410703685.6A Pending CN104352995A (zh) | 2014-11-30 | 2014-11-30 | 一种治疗胆结石的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104352995A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106620545A (zh) * | 2017-03-09 | 2017-05-10 | 李耀宗 | 一种治疗胆结石的药物及其制备方法 |
CN106728013A (zh) * | 2016-11-18 | 2017-05-31 | 苏州枫灵医药科技有限公司 | 一种治疗胆结石的中药组合物及制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102370950A (zh) * | 2011-11-17 | 2012-03-14 | 中国中医科学院中医临床基础医学研究所 | 一种治疗胆结石的中药复方制剂及其制备方法 |
-
2014
- 2014-11-30 CN CN201410703685.6A patent/CN104352995A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102370950A (zh) * | 2011-11-17 | 2012-03-14 | 中国中医科学院中医临床基础医学研究所 | 一种治疗胆结石的中药复方制剂及其制备方法 |
Non-Patent Citations (1)
Title |
---|
潘国良: "自拟舒胆汤治疗胆石症 75 例疗效观察", 《新中医》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106728013A (zh) * | 2016-11-18 | 2017-05-31 | 苏州枫灵医药科技有限公司 | 一种治疗胆结石的中药组合物及制备方法和应用 |
CN106620545A (zh) * | 2017-03-09 | 2017-05-10 | 李耀宗 | 一种治疗胆结石的药物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102772711B (zh) | 一种治疗痔疮的药物及其制备方法 | |
CN105327296A (zh) | 一种治疗消化性溃疡的药物及其制备方法 | |
CN102793822A (zh) | 一种治疗阑尾炎的药物及其制备方法 | |
CN103536888A (zh) | 一种治疗慢性盆腔炎的药物及其制备方法 | |
CN103550439A (zh) | 一种治疗带状疱疹的药物及其制备方法 | |
CN103736034A (zh) | 一种治疗胆囊炎的药物及其制备方法 | |
CN105477487A (zh) | 一种治疗慢性咽炎的药物及其制备方法 | |
CN104352995A (zh) | 一种治疗胆结石的药物及其制备方法 | |
CN104958626A (zh) | 一种治疗结肠炎的药物及其制备方法 | |
CN104398925A (zh) | 一种治疗皮肤病的药物及其制备方法 | |
CN103735916B (zh) | 一种治疗肾病综合症的药物及其制备方法 | |
CN104352709A (zh) | 一种治疗胃溃疡的药物及其制备方法 | |
CN105521473A (zh) | 一种治疗小儿麻痹后遗症的药物及其制备方法 | |
CN105412665A (zh) | 一种治疗麻疹的药物及其制备方法 | |
CN102657773B (zh) | 一种治疗阑尾炎的药物及其制备方法 | |
CN103751752B (zh) | 一种治疗痢疾的药物及其制备方法 | |
CN103721223B (zh) | 一种治疗功能性子宫出血的药物及其制备方法 | |
CN103830698B (zh) | 一种治疗儿童腹股沟疝的药物及其制备方法 | |
CN102671124B (zh) | 一种治疗胆红素结石的药物及其制备方法 | |
CN105343854A (zh) | 一种治疗胃脘痛的药物及其制备方法 | |
CN106109941A (zh) | 一种用于治疗乳汁淤积症的中药冲剂及制备方法 | |
CN105412825A (zh) | 一种治疗高脂血症的药物及其制备方法 | |
CN105381409A (zh) | 一种治疗胆石症的药物及其制备方法 | |
CN105343582A (zh) | 一种治疗破伤风的药物及其制备方法 | |
CN105381416A (zh) | 一种治疗上消化道出血的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150218 |